• 目的探讨NPEP方案晚期细胞肺癌近期疗效

    Objective To evaluate near therapeutic effect of advanced non small cell lung cancer (NSCLC), treated with NP regimen or EP regimen.

    youdao

  • 目的观察苦注射液加化疗单纯化疗晚期非小细胞肺癌疗效及毒副反应。

    Objective To compare the efficacy and side-effect of Kushen injection combined with chemotherapy and chemotherapy alone in the treatment of non-small cell lung cancer (NSCLC).

    youdao

  • 目的观察替尼单药治疗对晚期非小细胞肺癌NSCLC老年患者效果安全性

    Objective To evaluate the efficacy and safety of gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).

    youdao

  • 结论厄洛替尼单药晚期非小细胞肺癌合并COPD患者不良反应耐受性好疗效可接受。

    Conclusion For elderly patients with advanced non-small cell lung cancer and COPD, the use of erlotinib might achieve better security and effectiveness.

    youdao

  • 目的探讨康莱特注射液联合化疗晚期非小细胞肺癌(NSCLC)患者生活质量改善临床意义

    Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.

    youdao

  • 晚期非小细胞肺癌、且适合接受化疗靶向治疗患者一种行之有效安全治疗方法。

    For advanced non-small cell lung cancer, not suitable for or unwilling to accept the radiotherapy and chemotherapy, targeted therapy patients, is an effective and safe treatment.

    youdao

  • 目的明确肿瘤组织胰岛素生长因子-1受体IGF-1R)表达晚期非小细胞肺癌化疗疗效及生存影响

    ObjectiveTo explore the influence of the expression of insulin-like growth factor-1 receptor(IGF-1R)in end-stage non-small cell lung cancer.

    youdao

  • 结论:泰素加卡铂联合化疗方案晚期非小细胞肺癌疗效不良反应

    Conclusion: the efficacy of treating intermediate and late non-small cell lung cancer with combined taxol and carboplatin chemotherapy is fairly good. The adverse reactions are mild and tolerable.

    youdao

  • 方法30晚期细胞肺癌患者采用含泰素联合化疗至少化疗2周期

    Method: 30 patients with advanced non small cell lung cancer (NSCLC) were treated by Paclitaxel combined chemotherapy, which at least each of given 2 cycles.

    youdao

  • 方法33应用泰素卡铂治疗晚期非小细胞肺癌患者进行分析

    Methods Analysis of 33 cases of NSCLC treated by Taxol and Carboplatin.

    youdao

  • 方法33应用泰素卡铂治疗晚期非小细胞肺癌患者进行分析

    Methods Analysis of 33 cases of NSCLC treated by Taxol and Carboplatin.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定